4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-415540
Principal Accounting Officer sold 13 shares at $10.56 ($137)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowen Matthew Principal Accounting Officer | 2026-10-05 | Sale | −13 | $10.56 | $137 | 25,891 | D: show line 1 in the form |
| Open-market sales · 13 sh · avg $10.56 · $137 | |||||||
Loading xslF345X06/ownership.xml…